Cargando…
Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy
The frequency and types of adverse events after initial antithyroid drug (ATD) therapy during pregnancy have never been reported, nor has whether the frequency of adverse events is the same as among nonpregnant subjects ever been investigated. We investigated retrospectively the frequency of adverse...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913092/ https://www.ncbi.nlm.nih.gov/pubmed/24523983 http://dx.doi.org/10.1155/2014/952352 |
_version_ | 1782302175017304064 |
---|---|
author | Yoshihara, Ai Noh, Jaeduk Yoshimura Watanabe, Natsuko Iwaku, Kenji Kobayashi, Sakiko Suzuki, Miho Ohye, Hidemi Matsumoto, Masako Kunii, Yo Mukasa, Koji Sugino, Kiminori Ito, Koichi |
author_facet | Yoshihara, Ai Noh, Jaeduk Yoshimura Watanabe, Natsuko Iwaku, Kenji Kobayashi, Sakiko Suzuki, Miho Ohye, Hidemi Matsumoto, Masako Kunii, Yo Mukasa, Koji Sugino, Kiminori Ito, Koichi |
author_sort | Yoshihara, Ai |
collection | PubMed |
description | The frequency and types of adverse events after initial antithyroid drug (ATD) therapy during pregnancy have never been reported, nor has whether the frequency of adverse events is the same as among nonpregnant subjects ever been investigated. We investigated retrospectively the frequency of adverse events after initial ATD administration to previously untreated Graves' disease (GD) patients during pregnancy. We reviewed the charts of cases of 91 untreated pregnant women who came to our hospital for the first time and were newly diagnosed with GD during the period between January 1, 1999, and December 31, 2011. Thiamazole (MMI) was used to treat 40 patients and 51 patients were treated with propylthiouracil (PTU). Adverse events occurred in 5 patients (5/40; 12.5%) treated with MMI, and they consisted of cutaneous reactions in 5 patients. Adverse events occurred in five patients (5/51; 9.8%) treated with PTU, and they consisted of hepatotoxicity in two patients and cutaneous reactions in three patients. No patients experienced agranulocytosis or ANCA-related vasculitis. Comparison with the expected rate of adverse events in nonpregnant individuals showed that the frequency of adverse events in pregnant individuals was low. |
format | Online Article Text |
id | pubmed-3913092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-39130922014-02-12 Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy Yoshihara, Ai Noh, Jaeduk Yoshimura Watanabe, Natsuko Iwaku, Kenji Kobayashi, Sakiko Suzuki, Miho Ohye, Hidemi Matsumoto, Masako Kunii, Yo Mukasa, Koji Sugino, Kiminori Ito, Koichi J Thyroid Res Clinical Study The frequency and types of adverse events after initial antithyroid drug (ATD) therapy during pregnancy have never been reported, nor has whether the frequency of adverse events is the same as among nonpregnant subjects ever been investigated. We investigated retrospectively the frequency of adverse events after initial ATD administration to previously untreated Graves' disease (GD) patients during pregnancy. We reviewed the charts of cases of 91 untreated pregnant women who came to our hospital for the first time and were newly diagnosed with GD during the period between January 1, 1999, and December 31, 2011. Thiamazole (MMI) was used to treat 40 patients and 51 patients were treated with propylthiouracil (PTU). Adverse events occurred in 5 patients (5/40; 12.5%) treated with MMI, and they consisted of cutaneous reactions in 5 patients. Adverse events occurred in five patients (5/51; 9.8%) treated with PTU, and they consisted of hepatotoxicity in two patients and cutaneous reactions in three patients. No patients experienced agranulocytosis or ANCA-related vasculitis. Comparison with the expected rate of adverse events in nonpregnant individuals showed that the frequency of adverse events in pregnant individuals was low. Hindawi Publishing Corporation 2014 2014-01-09 /pmc/articles/PMC3913092/ /pubmed/24523983 http://dx.doi.org/10.1155/2014/952352 Text en Copyright © 2014 Ai Yoshihara et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Yoshihara, Ai Noh, Jaeduk Yoshimura Watanabe, Natsuko Iwaku, Kenji Kobayashi, Sakiko Suzuki, Miho Ohye, Hidemi Matsumoto, Masako Kunii, Yo Mukasa, Koji Sugino, Kiminori Ito, Koichi Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy |
title | Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy |
title_full | Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy |
title_fullStr | Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy |
title_full_unstemmed | Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy |
title_short | Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy |
title_sort | frequency of adverse events of antithyroid drugs administered during pregnancy |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913092/ https://www.ncbi.nlm.nih.gov/pubmed/24523983 http://dx.doi.org/10.1155/2014/952352 |
work_keys_str_mv | AT yoshiharaai frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT nohjaedukyoshimura frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT watanabenatsuko frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT iwakukenji frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT kobayashisakiko frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT suzukimiho frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT ohyehidemi frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT matsumotomasako frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT kuniiyo frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT mukasakoji frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT suginokiminori frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy AT itokoichi frequencyofadverseeventsofantithyroiddrugsadministeredduringpregnancy |